Hedge Fund and Insider Trading News: David Einhorn, Carl Icahn, Ken Griffin, Melvin Capital Management, Clene Inc. (CLNN), Hillman Solutions Corp (HLMN), and More

Bill Ackman Sells Netflix Stake After Post-Earnings Plunge (CNBC)
Pershing Square dumped its stake in Netflix Wednesday following the streaming service company’s disappointing quarterly report, founder and CEO Bill Ackman said in a letter to shareholders.

T. Rowe Price Says it Plans to Back Kohl’s Nominees in Proxy Fight with Macellum (Reuters)
BOSTON, April 20 (Reuters) – T. Rowe Price Associates, one of the biggest investors in Kohl’s Corp (KSS.N), said it plans to back all of the department store’s directors, dealing a setback to activist hedge fund Macellum Advisors as it tries to take control of the board.

Oaktree-Backed 17Capital Racks Up $2.9bn for Inaugural Credit Fund (Opalesque)
The London-based investment firm 17Capital, backed by Oaktree Capital, has made a final close of its inaugural lending fund at its hard cap of €2.6bn ($2.9 billion) and exceeding its initial €1.5bn target. The financier to buyout groups said that the 17Capital Credit Fund is the largest debut private credit fund raised globally since 2009 and is one of the largest debut funds ever raised. It will lend money to private equity funds that want to juice returns by using more leverage to strike deals.

Thursday 4/21 Insider Buying Report: CLNN, INZY (Nasdaq.com)
On Wednesday, Clene’s , David J. Matlin, made a $400,002 buy of CLNN, purchasing 132,891 shares at a cost of $3.01 a piece. Matlin was up about 5.0% on the purchase at the high point of today’s trading session, with CLNN trading as high as $3.16 at last check today. Clene is trading up about 0.7% on the day Thursday. Before this latest buy, Matlin bought CLNN on 6 other occasions during the past year, for a total investment of $2.93M at an average of $6.08 per share. And at Inozyme Pharma, there was insider buying on Tuesday, by SVP, COO Henric Bjorn Bjarke who purchased 27,100 shares at a cost of $3.69 each, for a total investment of $99,999. Inozyme Pharma is trading up about 18.4% on the day Thursday. So far Bjarke is in the green, up about 47.4% on their buy based on today’s trading high of $5.44.

Insiders Sell Around $140M Of 4 Stocks (Benzinga)
Hillman Solutions: The Trade: Hillman Solutions Corp. (HLMN) 10% owner CCMP Capital Associates Iii Gp Llc sold a total of 12,347,733 shares at an average price of $10.00. The insider received around $123.48 million from selling those shares. Target: The Trade: Target Corporation (TGT) Executive Officer Don Liu sold a total of 8,500 shares at an average price of $240.00. The insider received around $2.04 million from selling those shares.

Follow Insider Monkey on Twitter